{"id":"W2149953725","doi":"10.1093/annonc/mdt069","title":"Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"Breast Cancer Society of Canada; Beatrice Hunter Cancer Research Institute","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001628095,0.0003455227,0.0009411802,0.0005390404,0.0001942256,0.001552376,0.0005692192,0.001489525,0.007221433],"category_scores_gemma":[0.00923934,0.0001675417,0.0008933013,0.0007540057,0.0006917969,0.001870083,0.0003243187,0.001363889,0.0007212768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001619366,"about_ca_system_score_gemma":0.001520621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001350138,"about_ca_topic_score_gemma":0.003537893,"domain_scores_codex":[0.999265,0.0002907623,0.00008399379,0.00006316099,0.0001854938,0.0001115612],"domain_scores_gemma":[0.9963619,0.001968522,0.0006730713,0.0001186357,0.0003910386,0.0004868738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01077884,0.0009731649,0.02756458,0.001436339,0.001094529,0.0009696653,0.0000648079,0.002970268,0.003852243,0.006096392,0.03382245,0.9103767],"study_design_scores_gemma":[0.01085603,0.01990445,0.3972559,0.006827208,0.01143252,0.01213768,0.001694193,0.01611037,0.006200045,0.06052217,0.456683,0.0003764954],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3128979,0.3165273,0.003042595,0.3321855,0.00643673,0.0001539546,0.001273904,0.0001151953,0.02736701],"genre_scores_gemma":[0.8674222,0.08885041,0.002774555,0.02528714,0.01057979,0.0000799086,0.0006665185,0.00003430997,0.004305141],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.007221433,"threshold_uncertainty_score":0.02415812,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1411204572597438,"score_gpt":0.4968204685723518,"score_spread":0.355700011312608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}